Status:
COMPLETED
Probiotics for Treatment of Chalazion in Adults
Lead Sponsor:
University of Molise
Conditions:
Chalazion
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
There is growing evidence encouraging probiotics use in several diseases. The aim of the investigator's study is to define the possible beneficial impact of probiotics on adults suffering from chalazi...
Detailed Description
Prospective comparative pilot study on 20 adults suffering from chalazion randomly divided into two groups. The first group, received conservative treatment with lid hygiene, warm compression, and dex...
Eligibility Criteria
Inclusion
- history of rapid onset of painful inflamed mass that had reached a stationary size for more than 2 months
- clinical appearance and location of the lesion
Exclusion
- eyelid infection
- chalazion duration \< 1 month
- nonpalpable chalazion
- suspicion of malignancy
- comorbidities (constitutional atopy and seborrheic dermatitis, hormonal dysfunction, presence of irritable bowel disease, infectious mainly related to Staphylococcus aureus and Propionibacterium acnes, demodex mite infestation, vitamin A deficiency, arterial hypertension, diabetes and pregnancy)
- personal habits (smoking, eating disorders, etc.)
Key Trial Info
Start Date :
February 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 29 2020
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04342507
Start Date
February 1 2019
End Date
February 29 2020
Last Update
April 14 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Molise
Campobasso, Molise, Italy, 86100